About LGC Group
neuromet2 develops metrological approaches to facilitate confidence in clinical uptake of new methods for early diagnosis of alzheimer‘s disease and other neurodegenerative disorders... Read more
neuromet2 develops metrological approaches to facilitate confidence in clinical uptake of new methods for early diagnosis of alzheimer‘s disease and other neurodegenerative disorders... Read more